Discovery and Optimization of a Natural HIV-1 Entry Inhibitor Targeting the gp41 Fusion Peptide-Reference-Cited by-同舟云学术

Discovery and Optimization of a Natural HIV-1 Entry Inhibitor Targeting the gp41 Fusion Peptide

Published:2007-04 Issue:2 Volume:129 Page:263-275
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Münch Jan,Ständker Ludger,Adermann Knut,Schulz Axel,Schindler Michael,Chinnadurai Raghavan,Pöhlmann Stefan,Chaipan Chawaree,Biet Thorsten,Peters Thomas,Meyer Bernd,Wilhelm Dennis,Lu Hong,Jing Weiguo,Jiang Shibo,Forssmann Wolf-Georg,Kirchhoff Frank

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference47 articles.

1. Inhibition of HIV-1 gp160- dependent membrane fusion by a furin-directed alpha 1-antitrypsin variant;Anderson;J. Biol. Chem.,1993

2. HIV-1 resistance to the gp41-dependent fusion inhibitor C-34;Armand-Ugon;Antiviral Res.,2003

3. Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms;Brantly;Am. Rev. Respir. Dis.,1988

4. Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target;Chan;Proc. Natl. Acad. Sci. USA,1998

5. HIV-1 reverse transcription. A termination step at the center of the genome;Charneau;J. Mol. Biol.,1994

Cited by 226 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunological and homeostatic pathways of alpha -1 antitrypsin: a new therapeutic potential;Frontiers in Immunology;2024-08-19

2. Anti-biofilm peptides can rescue fluconazole and amphotericin B efficacies against Candida albicans;2024-08-16

3. Natural Variation in HIV-1 Entry Kinetics Map to Specific Residues and Reveal an Interdependence Between Attachment and Fusion;2024-06-25

4. gp120-derived amyloidogenic peptides form amyloid fibrils that increase HIV-1 infectivity;Cellular & Molecular Immunology;2024-03-05

5. HIV Biology: Detailed Insight into Virion Structural Organization and Its Pathogenesis;Emerging Human Viral Diseases, Volume II;2024